Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics, pharmacodynamics and safety of Andrographis paniculata capsules in COVID-19
TCTR20241123001Phase 2Recruiting
- Sponsor
- National Research Council of Thailand
- Start
- Nov 2024
- Countries
- 1
01
Overview
A Phase 2 trial of andrographis paniculata in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Started Nov 2024; status: recruiting.
02
Drugs
andrographis paniculata
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20241123001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241123001.